Hodgkin lymphoma
Advanced Classical Hodgkin Lymphoma: BrECADD Shows Noninferiority to eBEACOPP
SG Tylor
Source – BrECADD According to information from the Phase III HD21 trial (NCT02661503), which included patients with advanced classical Hodgkin ...
Adcetris Breakthrough: Six-Year Survival Data Reinforce Its Impact in Hodgkin Lymphoma Treatment
SG Tylor
Seagen has made a significant announcement regarding the updated U.S. Prescribing Information (PI) for Adcetris (brentuximab vedotin). The update includes ...
